*001339789
*00520210225151826.0
*007ta
*008200908s2020    no a   e m    00  0 eng
*00901883nam a2200373 c 4500
*019  $bl
*020  $a9788283776836$qheftet
*035  $a(EXLNZ-47BIBSYS_NETWORK)999921217593002201
*035  $a(NO-LaBS)14452630(bibid)
*040  $aNO-OsNB$bnob$erda
*060 4$aQV 744
*1001 $aHjelmeland, Knut$d1971-$0(NO-TrBIB)1602157051106$4aut$_61792000
*24510$aZopiclone impairment :$bcharacterization and measurement in an experimental study$cKnut Hjelmeland
*264 1$a[Oslo]$bUniversity of Oslo, Faculty of Medicine, Institute of Clinical Medicine$c2020
*300  $a1 bind (varierende paginering)$billustrasjoner$c25 cm
*336  $atekst$0http://rdaregistry.info/termList/RDAContentType/1020$2rdaco
*337  $auformidlet$0http://rdaregistry.info/termList/RDAMediaType/1007$2rdamt
*338  $abind$0http://rdaregistry.info/termList/RDACarrierType/1049$2rdact
*4901 $aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Oslo, 2020
*533  $aElektronisk reproduksjon$b[Norge]$cNasjonalbiblioteket Digital$d2020-10-07
*650 2$aBehavior Rating Scale$0(DNLM)D000067290$_61792100
*650 2$aDouble-Blind Method$0(DNLM)D004311$_61792200
*650 2$aEthanol$0(DNLM)D000431$_61792300
*650 2$aPiperazines$0(DNLM)D010879$_61792400
*650 2$aReaction Time$0(DNLM)D011930$_61792500
*7102 $aUniversitetet i Oslo$bDet medisinske fakultet$0(NO-TrBIB)90302138$4pbl$_10213300
*7102 $aUniversitetet i Oslo$bInstitutt for klinisk medisin$0(NO-TrBIB)15000758$4dgg$_10213400
*830 0$aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo$x1502-9921$w990122483394702201$_204428600
*85641$3Fulltekst$uhttps://www.nb.no/search?q=oaiid:"oai:nb.bibsys.no:999920088301502202"&mediatype=bøker$yNettbiblioteket$zSøke-URL
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999920088301502202$b2021-11-14T20:12:42Z$z999920088301502202
^